UBS OCONNOR LLC - SYNTA PHARMACEUTICALS CORP ownership

SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 86 filers reported holding SYNTA PHARMACEUTICALS CORP in Q4 2014. The put-call ratio across all filers is 1.76 and the average weighting 1.0%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of SYNTA PHARMACEUTICALS CORP
ValueSharesWeighting
Q1 2015$970,000,000
+96900.0%
500,000
+1900.0%
0.02%
Q4 2014$1,000,000
-75.0%
25,0000.0%0.00%
Q3 2014$4,000,000
-80.0%
25,0000.0%0.00%
Q2 2014$20,000,000
-41.2%
25,0000.0%0.00%
-100.0%
Q1 2014$34,000,00025,0000.00%
Other shareholders
SYNTA PHARMACEUTICALS CORP shareholders Q4 2014
NameSharesValueWeighting ↓
CAXTON CORP 28,639,349$123,436,00094.21%
Verity Asset Management, Inc. 103,021$456,0000.47%
NBW CAPITAL LLC 242,153$1,044,0000.27%
Old West Investment Management, LLC 69,997$301,0000.19%
IRONWOOD INVESTMENT MANAGEMENT LLC 196,639$848,0000.12%
SOPHROSYNE CAPITAL LLC 25,700$111,0000.10%
Cutler Capital Management, LLC 45,000$194,0000.08%
Rotella Capital Management, Inc. 11,700$50,0000.06%
STONERIDGE INVESTMENT PARTNERS LLC 66,397$286,0000.06%
Roundview Capital LLC 21,100$91,0000.04%
View complete list of SYNTA PHARMACEUTICALS CORP shareholders